June Health review

What it is

June Health trades at tryjunehealth.com as a direct-to-consumer telehealth storefront, headlining "Prescription treatments for weight loss, peptides, and hormone optimization — 100% online". Its weight-loss catalogue publishes per-dose price ladders: compounded semaglutide injectable from $179 a month across five tiers, semaglutide oral tablets from $187 rising to $329 across six, tirzepatide injectable from $179 across six, and oral tirzepatide from $249. It also sells a product branded MR-3, described in its own copy as retatrutide. Its peptides page names BPC-157, TB-500, sermorelin and ipamorelin only in explanatory passages about how peptides work; its hormone page names testosterone cypionate, thyroid T3/T4, estradiol, HCG and enclomiphene. Neither the peptide nor the hormone line carries a price.

How it works

Storefront-first: you browse the catalogue, a licensed clinician evaluation is stated as included in each displayed price, and medication ships with free discreet cold-chain delivery in two to three business days after approval. There are no long-term contracts and you can pause or cancel through the patient portal or by messaging the care team. On the hormone side, the practice describes testosterone replacement, thyroid optimisation and metabolic hormone balancing as guided by comprehensive lab work and licensed providers, which is the right framing for testosterone — though no lab pricing or protocol is published. The problems are structural rather than clinical. The footer's Terms of Service, Privacy Policy and HIPAA Notice links all resolve to dead in-page anchors, and direct URL guesses return the site's own 404 page, so there is no published agreement governing what you are buying, no privacy policy, and no HIPAA notice — for a business handling prescriptions and health information, that is not a cosmetic gap. No legal entity, prescribing medical group, governing law, refund policy or compounding pharmacy is named anywhere. No LegitScript or pharmacy-verification badge exists on the site. The domain was registered in May 2026, so there is no track record to weigh, and the catalogue shows signs of being assembled quickly — one product page displays a bottle image labelled for the wrong drug.

Pricing transparency

Published in detail for GLP-1s and nowhere at all for the reason this board exists. The weight-loss ladders are genuinely transparent — five and six dose tiers each, with the price at every step visible without signing up, and a "licensed clinician evaluation included" chip under each figure. But no peptide and no hormone carries a price anywhere on the site, and the catalogue at /shop returned a load failure at our check, so we are not quoting a figure for either. The $179-a-month GLP-1 entry price says nothing about what sermorelin, testosterone or enclomiphene would cost. Before starting a consultation, ask what each named molecule costs monthly, what dose and quantity that supplies, whether the price scales with dose the way the GLP-1 ladder does, whether lab work is required and what it costs, and — given the missing policy pages — get the refund and cancellation terms in writing, because there is no published document setting them out.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. No compounding pharmacy, prescribing medical group or legal entity is named anywhere on the site, and no LegitScript or equivalent pharmacy-verification badge appears — compounded sterile products are not reviewed by the FDA for purity and potency the way approved drugs are, so with no compounder named there is essentially nothing to evaluate on sourcing. On the peptide line, we can only assess molecules the site names, and it names four — BPC-157, TB-500, sermorelin and ipamorelin — in explanatory copy about how peptides work rather than as a purchasable menu, describing protocols as designed after evaluation. Those four are not evidence equivalents. Sermorelin and ipamorelin act on the growth-hormone axis, a real and well-described mechanism with thin long-term human outcome data and no controlled trial supporting the body-composition claims. BPC-157 and TB-500 have essentially no controlled human outcome trials at all; the tissue-repair reputation is inherited from animal studies and user reports. On the hormone line, testosterone therapy has a genuine evidence base together with real monitoring requirements and fertility suppression, and enclomiphene is named alongside it. Two further flags. The site sells a product branded MR-3, described in its own copy as retatrutide — an investigational molecule not approved anywhere for any indication. And its GLP-1 copy uses the phrase "clinically proven" for a compounded product that is not FDA-approved, which is the class of language the FDA flagged in its June 2026 warning-letter wave to telehealth companies over compounded-GLP-1 marketing; no warning letter naming this company was found. Individual results vary.

Pros and watch-outs

The evidence behind what June Health prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• Sermorelin: a real GHRH drug, read against the anti-aging pitch

  An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.

• Ipamorelin & CJC-1295: the honest evidence on GH secretagogue peptides

  They reliably raise growth hormone — that part is real. The muscle, fat-loss and anti-aging claims are not supported by human outcome data. A straight read.

• BPC 157: what the evidence actually shows (and what it doesn't)

  The 'healing peptide' has a deep rodent literature and almost no human data. A straight read of where the science stands.

• TRT: what testosterone therapy is actually proven to do

  An FDA-approved therapy for diagnosed hypogonadism — with real but moderate benefits (sexual function, mood; not vitality), cardiovascular non-inferiority in TRAVERSE, and a real fertility trade-off.

• Enclomiphene: the evidence for restoring testosterone without replacing it

  Randomized trials, including two Phase III RCTs, show enclomiphene restores a man's own testosterone while preserving fertility — but it was never FDA-approved.

How June Health compares

A few alternatives worth a look, depending on what you’re optimizing for.

• SLSystem Labs

  NAD⁺ bundled with glutathione, B-12 and sermorelin from one service

  See System Labs →
• Invigor Medical

  Prescription at-home NAD⁺ injections via telehealth

  See Invigor Medical →
• Defy Medical

  The widest physician-supervised peptide menu with lab testing

  See Defy Medical →